ADVERTISEMENT

GSK Pharma Q1 Results Review - Superior Execution, Lower Raw Material Costs Drive Earnings: Motilal Oswal

The brokerage believes that the stocks' current valuation adequately factors in the upside in the earnings.

<div class="paragraphs"><p>Various medicines arranged for photograph. (Source: freepik)</p></div>
Various medicines arranged for photograph. (Source: freepik)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More